Tangier disease is a familial disorder characterized by orange tonsils,
cholesterol ester deposition in reticuloendothelial cells, abnormal
chylomicron remnants, and a marked reduction in
high density lipoproteins. Plasma concentrations of the
apolipoproteins apo-A-I and
apoA-II in patients with
Tangier disease are approximately 1% and 7% of those in normal subjects, respectively. Previous studies have shown that the low plasma concentrations of
apoA-I and
apoA-II are due to increased fractional catabolism with a relatively normal
apoA-I and
apoA-II synthesis. Plasma
apoA-I and
apoA-II were isolated to electrophoretic homogeneity from delipidated plasma
lipoproteins from a patient with
Tangier disease.
ApoA-I Tangier differed from
apoA-I from control subjects in
amino acid composition, electrophoretic mobility, apparent molecular weight on
sodium dodecyl sulfate/
polyacrylamide gel electrophoresis, and heterogeneity of
isoforms on isoelectric focusing.
ApoA-II Tangier, however, appeared to be identical to normal
apoA-II in
amino acid composition and in immunological as well as chemical properties. These results have been interpreted as indicating that
apoA-I Tangier has a different covalent structure than does normal
apoA-I, and
apoA-II Tangier is identical to normal
apoA-II. This structural change in
apoA-I Tangier is associated with rapid catabolism of
apoA-I Tangier-and
apoA-II Tangier-containing plasma
lipoproteins, and it leads to the deficiency in
high density lipoproteins, abnormal
chylomicron remnants, and the intracellular accumulation of
cholesterol ester characteristic of
Tangier disease.